ArticlePediatric blood & cancer2020
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy.
Abstract readLetterComment
In one paragraph
Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 8 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 8 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- COVID-19 infection in children with blood cancer: A systematic review.Annals of hematology · 2025Pooled it
- The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.Frontiers in immunology · 2023Pooled it
- The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review.Frontiers in oncology · 2022Pooled it
- Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.Pediatric blood & cancer · 2021Pooled it
- Guideline
- Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.JCO global oncology · 2021Pooled it
- Pooled it
- Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis.Frontiers in oncology · 2020Pooled it
- SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients.Virology journal · 2025Article
- Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study.International journal of hematology-oncology and stem cell research · 2024Article
- The Impact COVID-19 Infection on Cancer Patients: A Tertiary Cancer Center Experience in Jordan.Cureus · 2023Article
- Humoral profiling of pediatric patients with cancer reveals robust immunity following anti-SARS-CoV-2 vaccination superior to natural infection.Pediatric blood & cancer · 2023Article
- Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.Cancers · 2023Article
- No Child Should Be Left Behind by COVID-19: A Report about the COVID-19 Pandemic Experience in Children and Adolescents with Acute or Chronic Disease Treated at a Pediatric Referral Hospital in Italy.Pediatric reports · 2023Article
- The clinical follow-up and management of COVID-19 in children and adolescents with an immunocompromised state or a malignancy.Turkish journal of medical sciences · 2022Article
- How the COVID-19 Pandemic Reshaped the Management of Leukemia and Affected Patient Outcomes.Current treatment options in oncology · 2022Review
- Managing Care during the COVID-19 Pandemic: The Point of View and Fears of Pediatric Cancer Patients' Families.Children (Basel, Switzerland) · 2022Article
- Observational
- Retrospective review of severe acute respiratory syndrome coronavirus-2 infection in children with acute leukemia from a tertiary care hospital in Northern India.Clinical and experimental pediatrics · 2022Article
- COVID-19 in Children with Cancer.Current oncology reports · 2022Review
Corrections and comments
- Comment on
Authors and funding
21 authors.
Andrea FerrariPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID https://orcid.org/0000-0002-4724-0517
Marco ZeccaDepartment of Pediatric Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID https://orcid.org/0000-0002-8818-1744
Carmelo RizzariPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.
Fulvio PortaOncology Unit, Ospedale dei Bambini, ASST-Spedali Civili of Brescia, Brescia, Italy.
Massimo ProvenziPediatric Oncology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Maddalena MarinoniPediatric Department, ASST-Sette Laghi, F. Del Ponte Hospital, Varese, Italy.
Richard Fabian SchumacherOncology Unit, Ospedale dei Bambini, ASST-Spedali Civili of Brescia, Brescia, Italy.
Roberto LukschPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID https://orcid.org/0000-0002-7203-4176
Monica TerenzianiPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID https://orcid.org/0000-0002-7080-6718
Michela CasanovaPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Filippo SpreaficoPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID https://orcid.org/0000-0002-5587-3509
Stefano ChiaravalliPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Francesca CompagnoDepartment of Pediatric Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Federica BruniPediatric Oncology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Chiara PiccoloPediatric Department, ASST-Sette Laghi, F. Del Ponte Hospital, Varese, Italy.
Laura BettiniPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.
Mariella D'AngiòPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.
Giulia Maria FerrariPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.
Andrea BiondiPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.
Maura MassiminoPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID https://orcid.org/0000-0002-5506-2001
Adriana BalduzziPediatric Department, University of Milano Bicocca, MBBM Foundation, ASST Monza Ospedale San Gerardo, Monza, Italy.ORCID https://orcid.org/0000-0002-5879-0610
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
HematologyMedical OncologyBetacoronavirusChildCoronavirus InfectionsCOVID-19HumansItalyPandemicsPneumonia, ViralSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.